https://www.globenewswire.com/fr/news-release/2025/09/30/3158558/0/en/Barinthus-Biotherapeutics-to-Combine-with-Clywedog-Therapeutics-to-Target-Metabolic-and-Autoimmune-Diseases.html
The combined company, Clywedog Therapeutics, will bring a portfolio that includes three differentiated, clinical stage product candidates which are being...
barinthus biotherapeuticscombineclywedog
https://www.globenewswire.com/fr/news-release/2025/09/30/3158744/0/en/Barinthus-Biotherapeutics-to-Combine-with-Clywedog-Therapeutics-to-Target-Metabolic-and-Autoimmune-Diseases.html
GERMANTOWN, MD and ALTRINCHAM, UK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The combined company, Clywedog Therapeutics, will bring a portfolio that includes...
barinthus biotherapeuticscombineclywedog